| | Other Issues: previous | next | latest | archiveReviews Tolvaptan and its potential in the treatment of hyponatremia Megan B Dixon and Y Howard Lien Ther Clin Risk Manag. 2008 December; 4(6): 1149–1155. Published online 2008 December. PMCID: PMC2643096 Gemcitabine and taxanes in metastatic breast cancer: a systematic review Vinay Gudena, Alberto J Montero, and Stefan Glück Ther Clin Risk Manag. 2008 December; 4(6): 1157–1164. Published online 2008 December. PMCID: PMC2643097 Treatment of severe psoriasis with infliximab JA Leman and AD Burden Ther Clin Risk Manag. 2008 December; 4(6): 1165–1176. Published online 2008 December. PMCID: PMC2643098 Recombinant human growth hormone in the treatment of Turner syndrome Bessie E Spiliotis Ther Clin Risk Manag. 2008 December; 4(6): 1177–1183. Published online 2008 December. PMCID: PMC2643099 Impact of PPIs on patient focused symptomatology in GERD ABR Thomson Ther Clin Risk Manag. 2008 December; 4(6): 1185–1200. Published online 2008 December. PMCID: PMC2643100 Mometasone furoate in the management of asthma: a review Ricardo A Tan and Jonathan Corren Ther Clin Risk Manag. 2008 December; 4(6): 1201–1208. Published online 2008 December. PMCID: PMC2643101 Febuxostat in the management of hyperuricemia and chronic gout: a review Miao Hu and Brian Tomlinson Ther Clin Risk Manag. 2008 December; 4(6): 1209–1220. Published online 2008 December. PMCID: PMC2643102 Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab Daanish Hoda, George R Simon, and Christopher R Garrett Ther Clin Risk Manag. 2008 December; 4(6): 1221–1227. Published online 2008 December. PMCID: PMC2643103 Bazedoxifene for the prevention of postmenopausal osteoporosis Luigi Gennari, Daniela Merlotti, Vincenzo De Paola, Giuseppe Martini, and Ranuccio Nuti Ther Clin Risk Manag. 2008 December; 4(6): 1229–1242. Published online 2008 December. PMCID: PMC2643104 Vinflunine in the treatment of bladder cancer Mark Bachner and Maria De Santis Ther Clin Risk Manag. 2008 December; 4(6): 1243–1253. Published online 2008 December. PMCID: PMC2643105 Treatment of grass pollen allergy: focus on a standardized grass allergen extract – Grazax® Moisés Calderón and Tove Brandt Ther Clin Risk Manag. 2008 December; 4(6): 1255–1260. Published online 2008 December. PMCID: PMC2643106 Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts? Rafael Zaragoza, Javier Pemán, Miguel Salavert, Ángel Viudes, Amparo Solé, Isidro Jarque, Emilio Monte, Eva Romá, and Emilia Cantón Ther Clin Risk Manag. 2008 December; 4(6): 1261–1280. Published online 2008 December. PMCID: PMC2643107 Once-daily fosamprenavir with ritonavir in the treatment of HIV infection in therapy-naïve patients Leo Flamholc and Magnus Gisslén Ther Clin Risk Manag. 2008 December; 4(6): 1281–1284. Published online 2008 December. PMCID: PMC2643108 Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate PH Chandrasekar Ther Clin Risk Manag. 2008 December; 4(6): 1285–1294. Published online 2008 December. PMCID: PMC2643109 Exemestane in early breast cancer: a review Michael Untch and Christian Jackisch Ther Clin Risk Manag. 2008 December; 4(6): 1295–1304. Published online 2008 December. PMCID: PMC2643110 Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis José Luis Callejas-Rubio, Lourdes López-Pérez, and Norberto Ortego-Centeno Ther Clin Risk Manag. 2008 December; 4(6): 1305–1313. Published online 2008 December. PMCID: PMC2643111 Tadalafil in the treatment of erectile dysfunction Robert M Coward and Culley C Carson Ther Clin Risk Manag. 2008 December; 4(6): 1315–1330. Published online 2008 December. PMCID: PMC2643112 Newer treatments for fibromyalgia syndrome Richard E Harris and Daniel J Clauw Ther Clin Risk Manag. 2008 December; 4(6): 1331–1342. Published online 2008 December. PMCID: PMC2643113 Effects of treatment with antimicrobial agents on the human colonic microflora Fatemeh Rafii, John B Sutherland, and Carl E Cerniglia Ther Clin Risk Manag. 2008 December; 4(6): 1343–1358. Published online 2008 December. PMCID: PMC2643114 Original Research Evaluation of cardiotoxicity five years after 2D planned, non-simulated, radiation therapy for left breast cancer Kyriaki Pistevou-Gompaki, Apostolos Hatzitolios, Nikos Eleftheriadis, Evaggelos Boultoukas, George Ntaios, Ioannis Andronikidis, and Ioannis Tzitzikas Ther Clin Risk Manag. 2008 December; 4(6): 1359–1362. Published online 2008 December. PMCID: PMC2643115 Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy Tamana Walia, J Fernando Quevedo, Timothy J Hobday, Gary Croghan, and Aminah Jatoi Ther Clin Risk Manag. 2008 December; 4(6): 1363–1366. Published online 2008 December. PMCID: PMC2643116 Takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer Thérèse H Franco, Ahmed Khan, Vishal Joshi, and Beje Thomas Ther Clin Risk Manag. 2008 December; 4(6): 1367–1370. Published online 2008 December. PMCID: PMC2643117 Safe and tolerable one-hour pamidronate infusion for multiple myeloma patients Dimitrios Chantzichristos, Björn Andréasson, and Peter Johansson Ther Clin Risk Manag. 2008 December; 4(6): 1371–1374. Published online 2008 December. PMCID: PMC2643118 Case Reports A thyrotoxicosis outbreak due to dietary pills in Paris Vincent Ioos, Vincent Das, Eric Maury, Jean-Luc Baudel, Jérôme Guéchot, Bertrand Guidet, and Georges Offenstadt Ther Clin Risk Manag. 2008 December; 4(6): 1375–1379. Published online 2008 December. PMCID: PMC2643119 Ther Clin Risk Manag. 2008 December; 4(6): 1381. Published online 2008 December. PMCID: PMC2643120 |